Report an error

Spotted something inaccurate in “Oral FGFR3 Inhibitor Shows Growth Benefits in Achondroplasia Children”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.